 The purpose of this clinical study is to evaluate the imaging performance of the Carestream PRO 3543 Detector and Carestream PRO 3543C Detector referred to as the investigational devices as compared to the currently marketed Carestream DRX-1 Detector referred to as the predicate device. Both detectors are flat panel digital imaging devices. The results of this study will be included in a Traditional 510k FDA Submission to obtain clearance to market the new detectors in the US. The study was designed in accordance with the FDA Guidance titled Guidance for the Submission of 510ks for Solid State X-ray Imaging Devices, issued on August 6, 1999. 